Novel Approaches for Topical Delivery of Acetazolamide

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-02-2002
Volume 26
Issue 7

Extensive research has been conducted to improve the solubility and permeability of acetazolamide in hopes that a topical formulation for the treatment of glaucoma can be developed.

External Link - article-24128.pdf

Articles in this issue
Congress Adopts New User Fee Program
Validation Basics: A System Developer's Approach to Validation
Rapid Headspace Oxygen Analysis for Pharmaceutical Packaging Applications
How to Engage in a Strategic Outsourcing Relationship
Particle-Size Distribution II: The Problem of Sampling Powdered Solids
Novel Approaches for Topical Delivery of Acetazolamide
Outsourcing Outlook
Electrodeionization in Pharmaceutical Water Treatment
Recent Videos
Related Content
Abnormal plasma cell or b-cell in multiple myeloma emitting paraprotein 3d illustration | Image Credit: © LASZLO - stock.adobe.com

CellCentric Completes $120 Million Series C Funding Round for Multiple Myeloma Treatment Inobrodib

Patrick Lavery
May 21st 2025
Article

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only multiple myeloma, but other specific cancers as well.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

IRVINE, CALIFORNIA - 16 APRIL 2020: Student Center and Visitor Center Building on the campus of the University of California Irvine, UCI. | Image Credit: © Steve Cukrov - stock.adobe.com

UC Irvine Lab Studies NLRP3 Inflammasome for Inflammatory Disease Treatment Potential

Patrick Lavery
May 19th 2025
Article

Researchers say they have discovered the first drug mechanism that binds to the pyrin domain to block NLRP3 and prevent a series of reactions resulting in inflammation.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

A laboratory technician performing a quality control test on a batch of pharmaceutical tablets, highlighting the importance of ensuring drug safety. | Image Credit: ©MAY -stock.adobe.com

Poor API Quality Threatens a Healthy Supply

Susan Haigney
May 9th 2025
Article

Poor API quality may often lead to delays in production and a shortage of supply.

Insulin Vial Trapped in Ice for Diabetic Challenges | Image Credit: ©Nisit – stock.adobe.com

Parenteral Formulation: Deciding When to Go Frozen or Freeze-Dried

Cynthia A. Challener
May 8th 2025
Article

Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.